TRIAMINIC DECONGEST+EXPECT LIQUI-GELS CAP
TRIAMINIC DECONGEST+EXPECT LIQUI-GELS CAP
Discontinued
DIN Number
02172437
Drug Class
Human
Market Date
Dec 31, 1995
Company
HC
Sandoz Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02172437
AIG Number0203205002
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R05CA10 COMBINATIONS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification48:16.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
GUAIFENESINActive
Strength: 100 MG / CAP
Monograph: GUAIFENESIN
PSEUDOEPHEDRINE HYDROCHLORIDEActive
Strength: 30 MG / CAP
Monograph: PSEUDOEPHEDRINE HYDROCHLORIDE